Marston's PLC (MARS) is a leading restaurants business based in the UK. It opened the day at 44.36p after a previous close of 45.74p. During the day the price has varied from a low of 42.84p to a high of 45.7838p. The latest price was 43.18p (25 minute delay). Marstons is listed on the London Stock Exchange (LSE) and employs 14,000 staff. All prices are listed in pence sterling.
Since the stock market crash in March caused by coronavirus, Marstons's share price has had significant negative movement.
Its last market close was 41.92p, which is 60.71% down on its pre-crash value of 106.7p and 127.83% up on the lowest point reached during the March crash when the shares fell as low as 18.4p.
If you had bought £1,000 worth of Marstons shares at the start of February 2020, those shares would have been worth £240.30 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £394.73.
|52-week range||18.4p - 133.8p|
|50-day moving average||45.81p|
|200-day moving average||47.7519p|
|Wall St. target price||108.33p|
|Dividend yield||0.07p (20.75%)|
|Earnings per share (TTM)||11.6p|
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2020-10-14)||-3.70%|
|1 month (2020-09-22)||4.75%|
|3 months (2020-07-21)||-10.60%|
|6 months (2020-04-21)||23.87%|
|1 year (2019-10-21)||-64.46%|
|2 years (2018-10-19)||-56.01%|
|3 years (2017-10-20)||-59.83%|
|5 years (2015-10-21)||-73.01%|
Valuing Marstons stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Marstons's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Marstons's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, Marstons shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
However, Marstons's P/E ratio is best considered in relation to those of others within the restaurants industry or those of similar companies.
Marstons's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.25. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Marstons's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
However, it's sensible to consider Marstons's PEG ratio in relation to those of similar companies.
Marstons's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £185.6 million.
The EBITDA is a measure of a Marstons's overall financial performance and is widely used to measure a its profitability.
To put Marstons's EBITDA into context you can compare it against that of similar companies.
|Revenue TTM||£1.1 billion|
|Operating margin TTM||12.1%|
|Gross profit TTM||£446.2 million|
|Return on assets TTM||2.84%|
|Return on equity TTM||-7.4%|
|Market capitalisation||£298.7 million|
TTM: trailing 12 months
We're not expecting Marstons to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
You may also wish to consider:
Marstons's shares were split on a 4:1 basis on 9 January 2007. So if you had owned 1 share the day before before the split, the next day you'd have owned 4 shares. This wouldn't directly have changed the overall worth of your Marstons shares – just the quantity. However, indirectly, the new 75% lower share price could have impacted the market appetite for Marstons shares which in turn could have impacted Marstons's share price.
Over the last 12 months, Marstons's shares have ranged in value from as little as 18.4p up to 133.8p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Marstons's is 1.4834. This would suggest that Marstons's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Marstons's beta into context you can compare it against those of similar companies.
Marston's PLC operates managed, franchised, tenanted, and leased pubs, bars, restaurants, and accommodations in the United Kingdom and internationally. The company operates through three segments: Destination and Premium, Taverns, and Brewing. It provides premium cask, kegs, and bottled and canned beers through its six breweries under the Pedigree, Hobgoblin, Wainwright, and Shipyard brands, as well as under the licensed brands, including Estrella Damm. The company distributes its beers through 12 depots and distribution centers to estates, supermarkets, other pubs, and leisure businesses. It operates through approximately 1,400 bars, pubs and lodges, breweries, depots, and offices; approximately 1,700 rooms; and 30 stand-alone lodges. The company also exports its beers to approximately 61 countries. It is also involved in the property management; telecommunications; and insurance businesses. The company was formerly known as The Wolverhampton & Dudley Breweries PLC and changed its name to Marston's PLC in January 2007. Marston's PLC was founded in 1834 and is headquartered in Wolverhampton, the United Kingdom.
Everything we know about the Virpax Pharmaceuticals IPO, plus information on how to buy it.
Everything we know about the Vivos Therapeutics IPO, plus information on how to buy it.
Everything we know about the Kiromic Biopharma IPO, plus information on how to buy it.
Everything we know about the Codiak BioSciences IPO, plus information on how to buy it.
Everything we know about the Triller IPO, plus information on how to buy it.
Everything we know about the Eastern Bank IPO, plus information on how to buy it.
Everything we know about the Wish IPO, plus information on how to buy it.
Everything we know about the MINISO Group Holding Limited IPO, plus information on how to buy it.
Everything we know about the Playboy IPO, plus information on how to buy it.
Everything we know about the iHuman IPO, plus information on how to buy it.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.